Alok Srivastava/LinkedIn, Khaled Musallam/LinkedIn
May 6, 2026, 02:23
Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn:
“When the worlds of thalassemia and hemophilia converge, impactful advances are inevitable.
Delighted to welcome Prof Alok Srivastava as Visiting Professor, Consultant Hematologist, and Deputy Chief of Cell and Gene Therapy and Hematology at Burjeel Cancer Institute.
Excited for what lies ahead as we build robust services and bring forward innovative therapies for patients with blood disorders.”
More posts featuring Khaled Musallam on Hemostasis Today.
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026